World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
72
Citations
15466
World Ranking
2345
National Ranking
1110

Xiao Ming Xu publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Xiao Ming Xu sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 207 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Xiao Ming Xu D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Xiao Ming Xu sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 72 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Central nervous system

Xiao Ming Xu spends much of his time researching Spinal cord, Spinal cord injury, Neuroscience, Schwann cell and Transplantation. His Spinal cord study combines topics from a wide range of disciplines, such as White matter, Regeneration, Central nervous system and Anatomy. His Spinal cord injury research integrates issues from Lesion, Pathology, Central nervous system disease, Transcription factor and Corticospinal tract.

His work carried out in the field of Neuroscience brings together such families of science as Neurotrophic factors, microRNA and Pathogenesis. His Schwann cell study integrates concerns from other disciplines, such as Neurotrophin, Retrograde tracing, Cord, Gliosis and Dorsal root ganglion. His studies deal with areas such as Grey matter and Cell biology as well as Transplantation.

His most cited work include:

  • Axonal regeneration into Schwann cell‐seeded guidance channels grafted into transected adult rat spinal cord (477 citations)
  • A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. (425 citations)
  • Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord (337 citations)

What are the main themes of his work throughout his whole career to date?

Xiao Ming Xu mostly deals with Spinal cord injury, Spinal cord, Neuroscience, Anatomy and Central nervous system. His Spinal cord injury research incorporates elements of Anesthesia, Internal medicine, Neuroprotection, Transplantation and Pathology. His Spinal cord study combines topics in areas such as Lesion, Neurotrophic factors, Schwann cell, Corticospinal tract and Cord.

Xiao Ming Xu has researched Neuroscience in several fields, including Neurite, Neurotrophin and Regeneration, Cell biology. Xiao Ming Xu usually deals with Cell biology and limits it to topics linked to Cell culture and Embryo. Xiao Ming Xu interconnects Laminectomy, Gliosis and Central nervous system disease in the investigation of issues within Anatomy.

He most often published in these fields:

  • Spinal cord injury (59.93%)
  • Spinal cord (59.23%)
  • Neuroscience (38.33%)

What were the highlights of his more recent work (between 2015-2021)?

  • Spinal cord injury (59.93%)
  • Spinal cord (59.23%)
  • Neuroscience (38.33%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Spinal cord injury, Spinal cord, Neuroscience, Anesthesia and Neuroprotection. The study incorporates disciplines such as Functional recovery, Anatomy, Atrophy, Pathology and Glial cell line-derived neurotrophic factor in addition to Spinal cord injury. His Spinal cord research focuses on Laminectomy in particular.

His Neuroscience study incorporates themes from Regeneration and Corticospinal tract. His study in Anesthesia is interdisciplinary in nature, drawing from both Head trauma and Ischemia. The Neuroprotection study combines topics in areas such as Excitotoxicity and Programmed cell death.

Between 2015 and 2021, his most popular works were:

  • The mTOR substrate S6 Kinase 1 (S6K1) is a negative regulator of axon regeneration and a potential drug target for Central Nervous System injury (43 citations)
  • The p53 Pathway Controls SOX2-Mediated Reprogramming in the Adult Mouse Spinal Cord (39 citations)
  • Label-Free Vibrational Spectroscopic Imaging of Neuronal Membrane Potential. (26 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Neuron

Spinal cord injury, Neuroscience, Spinal cord, Neuroprotection and Anesthesia are his primary areas of study. The concepts of his Spinal cord injury study are interwoven with issues in Functional recovery, Anatomy, Atrophy and Cord. His Neuroscience research is multidisciplinary, relying on both Lumbar and Regeneration.

Xiao Ming Xu has included themes like Lesion, Pathology, Neurotrophin and Astrocyte in his Spinal cord study. His Neuroprotection research is multidisciplinary, incorporating perspectives in Inflammation and Excitotoxicity, Programmed cell death. His biological study spans a wide range of topics, including Glial cell line-derived neurotrophic factor, Neurotrophic factors, Spinal Cord Regeneration and Axon.

Best Publications

  • Axonal regeneration into Schwann cell‐seeded guidance channels grafted into transected adult rat spinal cord

    Xiao Ming Xu;Véronique Guénard;Naomi Kleitman;Mary Bartlett Bunge

  • A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord.

    Xiao Ming Xu;Véronique Guénard;Naomi Kleitman;Patrick Aebischer

  • Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord

    Xiao Ming Xu;Aqing Chen;Veronique Guenard;Naomi Kleitman

  • PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration

    Rajeev Sivasankaran;Jiong Pei;Kevin C. Wang;Kevin C. Wang;Yi Ping Zhang

  • Regrowth of axons into the distal spinal cord through a Schwann-cell-seeded mini-channel implanted into hemisected adult rat spinal cord.

    Xiao Ming Xu;Shu-Xin Zhang;Huaying Li;Patrick Aebischer

  • Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells.

    Qilin Cao;Xiao Ming Xu;William H. DeVries;Gaby U. Enzmann

  • Altered MicroRNA Expression following Traumatic Spinal Cord Injury

    Nai Kui Liu;Xiao Fei Wang;Qing Bo Lu;Xiao Ming Xu

  • Schwann Cell Transplantation for Repair of the Adult Spinal Cord

    Martin Oudega;Martin Oudega;Xiao Ming Xu

  • Methylprednisolone inhibition of TNF-α expression and NF-kB activation after spinal cord injury in rats

    Jan Xu;Guangshun Fan;Shawei Chen;Yingji Wu

  • Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels.

    Norman I. Bamber;Huaying Li;Xiaobin Lu;Martin Oudega

  • Chondroitinase ABC enhances axonal regrowth through Schwann cell-seeded guidance channels after spinal cord injury

    C. H. Chau;D. K. Y. Shum;H. Li;J. Pei

  • Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury.

    Qilin Cao;Qian He;Qian He;Yaping Wang;Yaping Wang;Xiaoxin Cheng;Xiaoxin Cheng

  • Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca2+ channel complex

    Joel M. Brittain;Djane B. Duarte;Sarah M. Wilson;Weiguo Zhu

  • Methylprednisolone administration improves axonal regeneration into Schwann cell grafts in transected adult rat thoracic spinal cord

    Aqing Chen;Xiao Ming Xu;Naomi Kleitman;Mary Bartlett Bunge

  • INOS and nitrotyrosine expression after spinal cord injury

    Jan Xu;Gyeong Moon Kim;Shawei Chen;Ping Yan

  • GDNF-enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons.

    Liqun Zhang;Zhengwen Ma;George M. Smith;Xuejun Wen

  • Tumor Necrosis Factor Receptor Deletion Reduces Nuclear Factor-κB Activation, Cellular Inhibitor of Apoptosis Protein 2 Expression, and Functional Recovery after Traumatic Spinal Cord Injury

    Gyeong Moon Kim;Jan Xu;Jinming Xu;Sheng Kwei Song

  • Functional and electrophysiological changes after graded traumatic spinal cord injury in adult rat

    Qilin Cao;Yi Ping Zhang;Christopher Iannotti;Christopher Iannotti;William H. DeVries

  • Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons.

    Jian Zou;Yan Xia Wang;Fang Fang Dou;He Zuo Lü

  • Repulsive Wnt Signaling Inhibits Axon Regeneration after CNS Injury

    Yaobo Liu;Xiaofei Wang;Xiaofei Wang;Chin-Chun Lu;Rachel Kerman;Rachel Kerman

  • Glial cell line-derived neurotrophic factor-enriched bridging transplants promote propriospinal axonal regeneration and enhance myelination after spinal cord injury.

    Christopher Iannotti;Huayin Li;Ping Yan;Xiaobin Lu

Frequent Co-Authors

Arun K. Ghosh
Arun K. Ghosh Purdue University West Lafayette
Chung Y. Hsu
Chung Y. Hsu China Medical University
Dale R. Sengelaub
Dale R. Sengelaub Indiana University
George M. Smith
George M. Smith Temple University
George F. Martin
George F. Martin The Ohio State University
Mary Bartlett Bunge
Mary Bartlett Bunge University of Miami
Ji-Xin Cheng
Ji-Xin Cheng Boston University
Scott R. Whittemore
Scott R. Whittemore University of Louisville
Kwok-Fai So
Kwok-Fai So University of Hong Kong
Xiaoyan Jiang
Xiaoyan Jiang University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Xiao Ming Xu

Trending Scientists

Recently Published Articles